Updated August 4 at 6:04pm
Biotechnology
39 results total, viewing 1 - 10
Venture capitalists invested $124.1 million in Rhode Island companies in 2014, $42 million more than in 2013, and the largest amount to date, according to the MoneyTree Report by PricewaterhouseCoopers LLP and the National Venture Capital Association. more
ProThera Biologics has appointed Denice M. Spero as president and chief business officer. more
Steve Lombardi has been named CEO and president of Nabsys Inc., a life sciences company pioneering semiconductor-based tools for genomic analysis. more
To Amgen Inc.'s Senior Manager for Manufacturing Jimmy Fleming, the task of ensuring that he and his team are producing a quality product is of the utmost importance – professionally and personally. Fleming's sister is one of the more … more
EpiVax Inc. and Novozymes Biopharma entered into a license agreement for the development of treatments for autoimmune diseases, the companies announced on Monday. more
A Japanese biopharmaceutical company has contracted to begin using a protein-screening interface developed by Providence-based EpiVax Inc. more
(Updated, 5:14 p.m.) A Cherrystone Angel Group portfolio business has entered into an acquisition agreement of $140 million with a European buyer specializing in bio-analytical testing and genomic services. more
Medrobotics Corp. was named a “rising star” in the Smaller Business Association of New England Inc.’s 2015 New England Innovation Awards. more
Dr. Anne S. De Groot, EpiVax CEO and University of Rhode Island professor, has been named one of the most influential people in the vaccine industry by the national vaccine industry organization VaccineNation. more
The first two patients in IlluminOss Medical Inc.’s U.S. Lightfix clinical trial for the treatment of impending and pathologic fractures have been successfully treated at the Marshall University Joan C. Edwards School of Medicine. more
1 | 2 | 3 | 4 Next »